Resveratrol induces growth arrest through activation of FOXO transcription factors in prostate cancer cells [33] and suppresses the immune response through CD28/CTLA-4 and CD80 co-stimulatory pathways [34]. This evidence concerns the gene CTLA4 and prostate carcinoma.